Aarey Drugs & Pharmaceuticals Ltd. Share Price & Stock Analysis

Aarey Drugs & Pharmaceuticals Ltd. (BSE: 524412) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹324 Cr, it ranks #2,283 by market cap among the 6,197 Indian listed companies on FinBizNet, and #53 of 86 in Medicinal Chemicals and Botanical Products. At ₹115.75 (as of 16 Nov 2026), the share price is 0.2% below its 52-week high of ₹116.00 and 130.1% above its 52-week low of ₹50.31. The share price is up 16.0% over one year and up 36.3% over three months.

Key Metrics

Current Price₹115.75
Market Cap₹324 Cr
BSE Code524412
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio82
Return on Equity2.75%
Return on Assets1.23%
52-Week Range₹50.31 – ₹116.00
1-Year Price Change+16.0%
3-Month Price Change+36.3%
Beta (1Y)0.82
Dividend Yield0.00%
HeadquartersMumbai, Maharashtra
Websitewww.aareydrugs.com

Latest Quarterly Results — Q2 FY27

Revenue₹89 Cr
Net Profit₹1 Cr
Net Margin1.5%
EPS (Basic)₹0.43
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Aarey Drugs & Pharmaceuticals Ltd. Quarterly Revenue and Profit Trend

Aarey Drugs & Pharmaceuticals Ltd. reported revenue of ₹89 Cr in Q2 FY27, up 5.3% from ₹84 Cr in Q2 FY26 and up 98.6% from ₹45 Cr in Q1 FY27. It posted a net profit of ₹1 Cr for the quarter, against a net profit of ₹1 Cr in Q2 FY26 (up 34.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹45 Cr (Q1 FY27) to ₹189 Cr (Q4 FY26). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹89 Cr₹1 Cr1.5%
Q1 FY27₹45 Cr₹1 Cr2.3%
Q4 FY26₹189 Cr₹2 Cr0.8%
Q3 FY26₹96 Cr₹1 Cr0.6%
Q2 FY26₹84 Cr₹1 Cr1.2%
Q1 FY26₹102 Cr₹1 Cr1.3%
Q4 FY25₹108 Cr₹0 Cr0.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 41.45% of Aarey Drugs & Pharmaceuticals Ltd.'s shares as of Sept 2026, against 39.06% in Dec 2025 (+2.39 percentage points). Delivery averaged 66.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Products and Services

1. Trading and Manufacturing Activities-This segment engages in the manufacture and supply of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, food colours, and flavours.

Business Segments

1. Trading and Manufacturing Activities-100%

Aarey Drugs & Pharmaceuticals Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Aarey Drugs & Pharmaceuticals Ltd.₹324 Cr822.75%₹89 Cr+16.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Aarey Drugs & Pharmaceuticals Ltd.?

Aarey Drugs & Pharmaceuticals Ltd. is trading at ₹115.75, with a market capitalisation of ₹324 Cr.

Which sector does Aarey Drugs & Pharmaceuticals Ltd. belong to?

Aarey Drugs & Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Aarey Drugs & Pharmaceuticals Ltd.?

Aarey Drugs & Pharmaceuticals Ltd. has a P/E of 82 and a return on equity of 2.75%.

What is the stock symbol of Aarey Drugs & Pharmaceuticals Ltd.?

Aarey Drugs & Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524412.

How has Aarey Drugs & Pharmaceuticals Ltd.'s share price moved over the past year?

Aarey Drugs & Pharmaceuticals Ltd.'s share price is up 16.0% over one year and up 36.3% over three months. Its 52-week range is ₹50.31 to ₹116.00.

What were Aarey Drugs & Pharmaceuticals Ltd.'s latest quarterly results?

In Q2 FY27, Aarey Drugs & Pharmaceuticals Ltd. reported revenue of ₹89 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.43 (standalone, parsed from the company's exchange filing).

How have Aarey Drugs & Pharmaceuticals Ltd.'s revenue and profit changed over the past year?

Aarey Drugs & Pharmaceuticals Ltd. reported revenue of ₹89 Cr in Q2 FY27, up 5.3% from ₹84 Cr in Q2 FY26 and up 98.6% from ₹45 Cr in Q1 FY27.

What is the promoter holding in Aarey Drugs & Pharmaceuticals Ltd.?

Promoters held 41.45% of Aarey Drugs & Pharmaceuticals Ltd.'s shares as of Sept 2026, against 39.06% in Dec 2025 (+2.39 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.